Stock Anticipated Piggybacks 04/03/2018 05/02/2018 HHPHF

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
258
Stock Anticipated Piggybacks 04/03/2018

05/02/2018 HHPHF High Hampton Hldgs Corp. Ordinary Shares Pink Current
05/02/2018 NVGLF NV Gold Corp Ordinary Shares Pink Current
05/02/2018 TXHPF Technopro Holdings Inc. Ordinary Shares Pink Current
04/28/2018 WDDMF WeedMD Inc Ordinary Shares Pink Current
04/26/2018 DSLEF Desert Lion Energy Inc. Ordinary Shares Pink Current
04/26/2018 PWWBF Powerband Solutions Inc. Ordinary Shares Pink Current
04/22/2018 BPRMF Blue Prism Group PLC Ordinary Shares Pink Current
04/20/2018 AMSLF Australian Mines Ltd. Ordinary Shares OTCQB
04/20/2018 HALMY Halma PLC American Depository Receipts Pink Current
04/19/2018 NMBF NMB Finl. Corp Common Stock Pink Current
04/18/2018 RPCGY RPC Group Plc American Depository Receipts Pink Current
04/18/2018 RVVQF Ravenquest Biomed Inc. Ordinary Shares OTCQB
04/15/2018 4SPOT Spotify Technology S.A. OTC Red
04/15/2018 JKPTF Jackpot Joy Plc Ordinary Shares Pink Current
04/15/2018 MTCPY MTR Corporation Ltd. American Depository Receipts Pink Current
04/14/2018 CLPBF Coloplast AS Ordinary Shares Pink Current
04/14/2018 DNNGY Orsted A/S American Depository Receipts Pink Current
04/14/2018 HPGLY "Hapag Llyod AG" American Depository Receipts Pink Current
04/12/2018 CYXTF Cryptoglobal Corp. Ordinary Shares Pink Current
04/11/2018 ASLEF Asaleo Care Ltd Ordinary Shares Pink Current
04/11/2018 BOUYF Bouygues SA Ordinary Shares Pink Current
04/11/2018 HGHH High Desert Hldg. Corp. Common Stock Pink Current
04/08/2018 AESTY AES Tiete Energia SA American Depository Receipts Pink Current
04/08/2018 BICEY BIC SA American Depository Receipts Pink Current
04/08/2018 GNZUF Guangzhou Automobile Group Co., Ltd. Ordinary Shares Pink Current
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Protecting Shareholder Rights: iRhythm Technologies Update

Updated Category News Views 104

Understanding Your Rights as a Shareholder For shareholders of iRhythm Technologies, Inc. (NASDAQ: IRTC), it's imperative to be proactive regarding your rights. Engaging with legal experts can significantly empower your ability to affect change and seek justice for any personal or collective grievances stemming from corporate actions. Why Shareholder Action is Crucial...

Continue Reading
Discover the New Credit Risk IQ and its Industry Insights

Updated Category News Views 138

Introducing Credit Risk IQ Credit Benchmark, a leader in delivering essential credit risk data and analytics, has launched an exciting new platform called Credit Risk IQ. This online portal features an extensive library of over 5,000 free monthly reports that explore credit trends at both industry and sector levels. The insights found in these reports are invaluable for...

Continue Reading
9Rooftops Retained as Marketing Agency for South Carolina Tourism

Updated Category News Views 233

9Rooftops Reappointed for South Carolina Tourism Marketing 9Rooftops, known for its innovative marketing strategies, has been reappointed as the Marketing and Advertising Agency of Record for the South Carolina Department of Parks, Recreation & Tourism (SCPRT). This marks a continued partnership aimed at showcasing the beauty and attractions of South Carolina. A...

Continue Reading
Kyivstar Enhances Digital Services with AI Cloud Solutions

Updated Category News Views 203

Kyivstar Revolutionizes Cloud Services with AI Integration Kyivstar Group Ltd (Nasdaq: KYIV; KYIVW) has embarked on an ambitious journey to strengthen digital services within Ukraine. The company has officially announced the integration of groundbreaking artificial intelligence (AI) technologies into its cloud platform, Kyivstar Cloud. This advancement is pivotal for all...

Continue Reading
Akeso Advances Cancer Care with Ivonescimab Phase III Trial Launch

Updated Category News Views 171

Akeso Launches Phase III Trial for Ivonescimab in SCLC Akeso, Inc. (9926.HK) recently announced an exciting milestone in cancer treatment with the first patient being dosed in its Phase III clinical trial. This multicenter, randomized, and double-blind study, named AK112-311/HARMONi-9, evaluates the efficacy and safety of ivonescimab, a unique bispecific antibody that...

Continue Reading